Prefrontal neurons and the genetics of schizophrenia

Biological Psychiatry

Volumn 50, Issue 11, 2001, Pages 825-844

  Weinberger, Daniel R ^a   Egan, Michael F ^a   Bertolino, Alessandro ^a   Callicott, Joseph H ^a   Mattay, Venkata S ^a   Lipska, Barbara K ^a   Berman, Karen F ^a   Goldberg, Terry E ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

COMT; Genetics; Neurobiology; Prefrontal cortex; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE;

ALLELE; BRAIN FUNCTION; COGNITION; CONFERENCE PAPER; ENZYME ACTIVITY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFORMATION PROCESSING; MENTAL DISEASE; NEUROTRANSMISSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; WORKING MEMORY;

ALLELES; ANIMALS; CATECHOL O-METHYLTRANSFERASE; COGNITION; DOPAMINE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MODELS, BIOLOGICAL; NEURONS; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 0035660267     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01252-5     Document Type: Conference Paper

References (214)

1. Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort
2. Differential EEG patterns in affective disorder and schizophrenia
3. Guilt by association
4. I. PET studies of memory: Novel and practiced free recall of complex narratives
5. Schizophrenia and cognitive dysmetria: A positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry
6. Hypofrontality in schizophrenia: Distributed dysfunctional circuits in neuroleptic-naive patients
7. "Cognitive dysmetria" as an integrative theory of schizophrenia: A dysfunction in cortical-subcortical-cerebellar circuitry?
8. Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease
9. Dissociating working memory from task difficulty in human prefrontal cortex
10. Selective attention in schizophrenia: Relationship to verbal working memory
11. Deficits in small interneurons in prefrontal and anterior cingulate cortex of schizophrenic and schizoaffective patients
12. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia
13. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia
14. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia
15. Regionally specific neuronal pathology in untreated patients with schizophrenia: A proton magnetic resonance spectroscopic imaging study
16. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia
17. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia
18. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia
19. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging
20. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging
21. Postpubertal emergence of prefrontal neuronal deficits and altered dopaminergic behaviors in rats with neonatal hippocampal lesions
22. Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: A proton magnetic resonance spectroscopic imaging study
23. Proton magnetic resonance spectroscopy in schizophrenia
24. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
25. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22
26. PET and MRI of the thalamus in never-medicated patients with schizophrenia
27. The dysplastic net hypothesis: An integration of developmental and dysconnectivity theories of schizophrenia
28. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia
29. Regional cerebral blood flow (rCBF) in schizophrenia during verbal memory activation: A 99 mTc-HMPAO single photon emission tomography (SPET) study
30. Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia
31. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited
32. Altered prefrontal cortical function in unaffected siblings of patients with schizophrenia
33. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI
34. Functional magnetic resonance imaging brain mapping in psychiatry: Methodological issues illustrated in a study of working memory in schizophrenia
35. Neuropsychiatric dynamics: The study of mental illness using functional magnetic resonance imaging
36. The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia
37. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers
38. Hippocampal afferents to the rat prefrontal cortex: Synaptic targets and relation to dopamine terminals
39. Projections from the rat prefrontal cortex to the ventral tegmental area: Target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons
40. Anterior cingulate cortex, error detection, and the online monitoring of performance
41. Functional hypofrontality and working memory dysfunction in schizophrenia
42. Prefrontal and temporal blood flow in schizophrenia: Resting and activation technetium-99 m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease
43. Eye movements in schizophrenia: A quantitative analysis
44. Inactivation of parietal and prefrontal cortex reveals interdependence of neural activity during memory-guided saccades
45. N-acetyl aspartate: A marker for neuronal loss or mitochondrial dysfunction
46. Impaired attention, genetics, and the pathophysiology of schizophrenia
47. Attenuated frontal activation during a verbal fluency task in patients with schizophrenia
48. Attenuated frontal activation in schizophrenia may be task dependent
49. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia
50. Linkage disequilibrium on the COMT gene in French schizophrenics and control subjects
51. Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia
52. Decreased left frontal lobe N-acetylaspartate in schizophrenia
53. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy
54. Chemical pathology of acute demyelinating lesions and its correlation with disability
55. Short-term functional plasticity of cortical and thalamic sensory representations and its implication for information processing
56. Prediction of cognitive decline in early Alzheimer's disease
57. Relative risk for cognitive impairments in siblings of patients with schizophrenia
58. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia
59. Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primates
60. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: A 4-year follow-up study
61. Brain activations in schizophrenia during a graded memory task studied with functional neuroimaging
62. Wisconsin Card Sorting Test: An indicator of vulnerability to schizophrenia?
63. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
64. Schizophrenia: A disconnection syndrome?
65. The left medial temporal region and schizophrenia: A PET study
66. Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex
67. Neuronal activity related to saccadic eye movements in the monkey's dorsolateral prefrontal cortex
68. Functional interactions between inferotemporal and prefrontal cortex in a cognitive task
69. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis
70. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits
71. Cognitive improvement during Tolcapone treatment in Parkinson's disease
72. Bipolar illness and schizophrenia as oligogenic diseases: Implications for the future
73. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
74. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior
75. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia
76. Uncoupling cognitive workload and prefrontal cortical physiology: A PET rCBF study
77. Regional cerebral blood flow and cognitive function in Huntington's disease and schizophrenia: A comparison of patients matched for performance on a prefrontal-type task
78. Performance of schizophrenic patients on putative neuropsychological tests of frontal lobe function
79. Genetic risk of neuropsychological impairment in schizophrenia: A study of monozygotic twins discordant and concordant for the disorder
80. Learning and memory in monozygotic twins discordant for schizophrenia
81. Probing prefrontal function in schizophrenia with neuropsychological paradigms
82. Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test
83. The physiological approach: Functional architecture of working memory and disordered cognition in schizophrenia
84. Schizophrenia genetics at the millennium: Cautious optimism
85. What are the functional consequences of neurocognitive deficits in schizophrenia?
86. Bilateral brain dysfunction during motor activation in type II schizophrenia measured by EEG mapping
87. Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features
88. Integrity of the mesocortical dopaminergic system is necessary for complete expression of in vivo hippocampal-prefrontal cortex long-term potentiation
89. A neural model of the dynamic activation of memory
90. Dimensional complexity of EEG waveforms in neuroleptic-free schizophrenic patients and normal control subjects
91. Eye-tracking dysfunctions in schizophrenic patients and their relatives
92. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness
93. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
94. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging
95. Distribution of cerebral activity in chronic schizophrenia
96. Smooth pursuit eye movements in childhood-onset schizophrenia: Comparison with attention-deficit hyperactivity disorder and normal control subjects
97. Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice
98. 1H NMR spectroscopy studies of Huntington's disease: Correlations with CAG repeat numbers
99. Profound neuronal plasticity in response to inactivation of the dopamine transporter
100. The acquisition of skilled motor performance: Fast and slow experience-driven changes in primary motor cortex
101. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: Reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model
102. Computed electroencephalographic activity mapping in schizophrenia: The resting state reconsidered
103. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophenia: A possible neurochemical basis for 'hypofrontality'
104. Reduced auditory P300 amplitude, medial temporal volume reduction and psychopathology in schizophrenia
105. SPECT analysis of regional cerebral blood flow changes in patients with schizophrenia during the Wisconsin Card Sorting Test
106. A pen-and-paper human analogue of a monkey prefrontal cortex activation task: Spatial working memory in patients with schizophrenia
107. Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of High-Density Schizophrenia Families: Evidence for possible etiologic heterogeneity
108. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families
109. Magnetic resonance spectroscopy in schizophrenia: Methodological issues and findings - Part II
110. Interaction of COMT gene deletion and environment on cognition
111. Neuropsychological risk indicators for schizophrenia: A review of family studies
112. Catechol-O-methyltransferase polymorphisms and schizophrenia: A transmission disequilibrium study in multiply affected families
113. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders
114. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects
115. Psychiatric genetics: Search for phenotypes
116. Development of the prefrontal cortex during adolescence: Insights into vulnerable neural circuits in schizophrenia
117. Dopamine transporter immunoreactivity in monkey cerebral cortex
118. Family-based linkage disequilibrium mapping using SNP marker haplotypes: Application to a potential locus for schizophrenia at chromosome 22q11
119. Preferential transmission of the high activity allele of COMT in schizophrenia
120. Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital
121. Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats
122. Attenuated extracellular dopamine levels after stress and amphetamine in the nucleus accumbens of rats with neonatal ventral hippocampal damage
123. Excitotoxic lesions of the rat medial prefrontal cortex: Effects on abnormal behaviors associated with neonatal hippocampal damage
124. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia
125. To model a psychiatric disorder in animals: Schizophrenia as a reality test
126. Synaptic pathology in prefrontal cortex and nucleus accumbens of adult rats with neonatal hippocampal damage
127. A quantitative analysis of smooth pursuit eye tracking in monozygotic twins discordant for schizophrenia
128. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme
129. Executive-frontal lobe cognitive dysfunction in schizophrenia: A symptom subtype analysis
130. A functional polymorphism in the COMT gene and performance on the Wisconsin Card Sort Test
131. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance
132. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI
133. Dextroamphetamine enhances "neural network-specific" physiological signals: A positron-emission tomography rCBF study
134. Effects of dextroamphetamine on cognitive performance and cortical activation
135. Dopaminergic modulation of working memory circuitry in patients with Parkinson's disease
136. Mapping cognition to the brain through neural interactions
137. SPET study of verbal fluency in schizophrenia and epilepsy
138. Large-scale neurocognitive networks and distributed processing for attention, language, and memory
139. Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats
140. The prefrontal cortex and cognitive control
141. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex
142. Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain
143. Neonatal damage of the rat ventral hippocampus impairs acquisition of a working memory task
144. Lithium increases N-acetyl-aspartate in the human brain: In vivo evidence in support of bcl-2's neurotrophic effects?
145. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo
146. Word recall in schizophrenia: A connectionist model
147. Effects of neonatal hippocampal lesions on prefrontal cortical pyramidal cell responses to VTA stimulation
148. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles
149. The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm
150. Schizophrenics show spatial working memory deficits
151. Information processing in large-scale cerebral networks: The causal connectivity approach
152. Schizophrenia: A disease of heteromodal association cortex?
153. The effects of practice on the functional anatomy of task performance
154. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects
155. Search for schizophrenia susceptibility genes
156. Sequential strategy to identify a susceptibility gene for schizophrenia: Report of potential linkage on chromosome 22qI
157. Source origin of a 50-msec latency auditory evoked field component in young schizophrenic men
158. The future of genetic studies of complex human diseases
159. Local and downstream effects of excitotoxic lesions in the rat medial prefrontal cortex on in vivo 1H-MRS signals
160. Apolipoprotein E and Alzheimer's disease: The tip of the susceptibility iceberg
161. The roles of prefrontal brain regions in components of working memory: Effects of memory load and individual differences
162. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood
163. Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine
164. Regional cerebral blood flow in Down syndrome adults during the Wisconsin Card Sorting Test: Exploring cognitive activation in the context of poor performance
165. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task
166. Neuronal coding of prediction errors
167. D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat
168. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons
169. Thalamic and amygdala-hippocampal volume reductions in first degree relatives of patients with schizophrenia: An MRI-based morphometry analysis
170. The reduced neuropil hypothesis: A circuit based model of schizophrenia
171. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter
172. Prefrontal cortical efferents in the rat synpase on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area
173. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex
174. Neural correlates of motor memory consolidation
175. Eye-tracking performance in psychiatric patients
176. Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia
177. Lack of normal pattern of cerebral asymmetry in familial schizophrenic patients and their relatives - The Maudsley Family Study
178. Effects of lesions in the medial prefrontal cortex on the activity of midbrain dopamine neurons
179. Deficits in sensory gating in schizophrenic patients and their relatives: Evidence obtained with auditory evoked responses
180. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)
181. Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional magnetic resonance imaging
182. Working and strategic memory deficits in schizophrenia
183. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: Evidence for genetic heterogeneity
184. A neural network model with dopamine-like reinforcement signal that learns a spatial delayed response task
185. Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo
186. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics
187. Low frontal electroencephalographic coherence in neuroleptic-free schizophrenic patients
188. Top-down signal from prefrontal cortex in executive control of memory retrieval
189. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains
190. Genotypes, phenotypes, and the brain: A search for connections in schizophrenia
191. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
192. Changing patterns of brain activation during maze learning
193. Effects of physical connectivity on the representational unity of multi-part configurations
194. Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy
195. Brain activation during cognitive stimulation with the Wisconsin Card Sorting Test: A functional MRI study on healthy volunteers and schizophrenics
196. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect
197. Implications of normal brain development for the pathogenesis of schizophrenia
198. Anteromedial temporal-prefrontal connectivity: A functional neuroanatomical system implicated in schizophrenia
199. A connectionist approach to the prefrontal cortex
200. Cell biology of the hippocampal formation in schizophrenia
201. Neuroimaging in the postgenome era
202. Prefrontal cortical blood flow and cognitive function in Huntington's disease
203. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: III. A new cohort and evidence for a monoaminergic mechanism
204. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: A magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins
205. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow evidence
206. Familial aspects of CT scan abnormalities in chronic schizophrenic patients
207. Methylation pharmacogenetics: Catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase
208. How many diseases does it take to map a gene with SNPs?
209. Word and tone working memory deficits in schizophrenia
210. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex
211. Patterns of neuropsychological deficits that discriminate schizophrenic individuals from siblings and control subjects